Browse Categories
Search
Stay In Touch
Login
|
|
Home > All Products > Optimal Resource Allocation and Capacity Planning for Biopharma and CRO
Optimal Resource Allocation and Capacity Planning for Biopharma and CRO
Price: From $298.00 to $1,200.00
Product Options
| |
|
Efficient strategic capacity planning and resource allocation is becoming a hot topic for biopharmaceutical companies and Clinical Research Organizations (CRO) due to increasing pressure to reduce cost of drug development. It is critical for many clinical organizations to find a better approach to increase effectiveness in resource capacity planning, especially for portfolio of clinical trials.
For both biopharmaceutical company and CRO, optimal capacity planning solution means:
-
Optimal resource utilization
-
Optimal resource allocation between ongoing and new trials
-
Optimal outsourcing strategy
-
Identification of resource bottleneck
-
Optimal scheduling of new trials
-
Optimal hiring and budget allocation strategy for a variety of employee roles
-
Understaffing risk assessment
-
Optimal resource reallocation due to a new trial inclusion or trial cancellation
Biopharmaceutical companies could also benefit from optimal scheduling of new trials. CROs can define maximum "throughput" of clinical trials based on current and projected manpower supply as well as clinical trials allocation across therapeutic areas, and stages of development.
ORBee Consulting developed powerful decision-making methodology based on rigorous mathematical models for optimal capacity planning and resource allocation in clinical research. Our technique saves money (up to 30%) by uncovering better resource allocation solutions.
What you will learn:
-
How to apply optimization technology to capacity planning in biopharma
-
How to optimize capacity planning and resource allocation across portfolio of clinical trials for both biopharma companies and CROs
-
How to identify resource bottleneck using optimization tools
-
How to reallocate resources due to inclusion or cancellation of clinical trials
-
How to calculate understaffing risk
Who should purchase:
You will benefit from purchasing this event if you are a CMO, CSO or senior level vice president or director from a CRO or a biopharma manufacturer with responsibilities or involvement in the following areas:
Clinical Operations
Clinical Research
Clinical Project Manager
Patient Recruitment & Retention
Clinical Studies/Trials
Clinical Program Development
Clinical Affairs
Medical Director
Clinical Development
About our Presenter:
Vladimir Shnaydman, Ph.D.
President
ORBee Consulting
As President of ORBee Consulting Vladimir Shnaydman is responsible for overall operations of the company, developing mathematical models and software. He contributed to many industries, including life science, computer networking, manufacturing, transportation, hydrology and water resources. Prior to founding ORBee Consulting, Vladimir worked at Biogen Idec, EMC, Netcracker Technology, Tufts University, and Russian Academy of Sciences, developing modeling solutions to improve efficiency in planning, operations, and performance analysis. Vladimir Shnaydman earned a Bachelor and Master of Sciences in Electrical Engineering and Computer Science, Master of Sciences in Applied Mathematics from Moscow State University and Ph.D. from Russian Academy of Sciences. He is author of more than 50 papers and co-author of three books.
|
|
|
|